HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined treatment of metastatic osteosarcoma of the spine.

Abstract
We report on a 28-year-old male with a single metastasis of an osteosarcoma in the twelfth thoracic vertebra occurring 9 years after initial diagnosis of the primary tumour in the left distal femur and neoadjuvant treatment according to a modified T-10 protocol. After pre-operative second-line combination chemotherapy with doxorubicin, carboplatin and etoposide leading to regression of the primarily inoperable metastasis wide resection of the tumour employing total spondylectomy was done. The duration of response had been 65 months since the end of subsequent postoperative chemotherapy with the same regimen.
AuthorsT Bauernhofer, H Stöger, A K Kasparek, F Ploner, I Kuss, T R Pieber, R Kotz, H Samonigg
JournalOncology (Oncology) Vol. 57 Issue 4 Pg. 265-8 (Nov 1999) ISSN: 0030-2414 [Print] Switzerland
PMID10575309 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright 1999 S. Karger AG, Basel
Chemical References
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Etoposide
  • Doxorubicin
  • Carboplatin
Topics
  • Adult
  • Antibiotics, Antineoplastic (administration & dosage)
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carboplatin (administration & dosage)
  • Chemotherapy, Adjuvant
  • Doxorubicin (administration & dosage)
  • Etoposide (administration & dosage)
  • Femoral Neoplasms (pathology)
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Osteosarcoma (diagnostic imaging, drug therapy, secondary, surgery, therapy)
  • Spinal Neoplasms (diagnostic imaging, drug therapy, secondary, surgery, therapy)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: